Identification of potential target genes of breast cancer in response to Chidamide treatment

Chidamide, a new chemically structured HDACi-like drug, has been shown to inhibit breast cancer, but its specific mechanism has not been fully elucidated. In this paper, we selected ER-positive breast cancer MCF-7 cells and used RNA-seq technique to analyze the gene expression differences of Chidami...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Han, Feng, Xue, Guo, Yarui, Cheng, Meijia, Cui, Zhengguo, Guo, Shanchun, Zhou, Weiqiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Molecular Biosciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9679413/
https://www.ncbi.nlm.nih.gov/pubmed/36425653
http://dx.doi.org/10.3389/fmolb.2022.999582

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9679413/
https://www.ncbi.nlm.nih.gov/pubmed/36425653
http://dx.doi.org/10.3389/fmolb.2022.999582

Ejemplares similares